Head of Clinical Research and Development
Ruben Giorgino brings 30+ years of experience in the pharmaceutical industry to Azafaros, with profound knowledge in clinical research, development and regulatory procedures of rare disease therapeutics. He previously held the position of Global Head of the Clinical Research and Development of the Helsinn Group, a company with early and late stage clinical assets in cancer therapeutics and supportive care and therapeutics. Prior to Helsinn, he held Global Clinical Development and Medical Affairs leadership roles at Actelion Pharmaceuticals in the lysosomal storage diseases area, including clinical development for neuronopathic Gaucher disease, Niemann-Pick type C disease and gangliosidoses. With more than 20 years of experience in the pharmaceutical industry he brings to Azafaros a profound knowledge and leadership in clinical development. He received his M.D. and Ph.D. from the Catholic University of Rome and is Board Certified in Obstetrics and Gynecology.